Caught Out By Ameresco's Slide? Here's What The Bears Saw

If you only glanced at Ameresco’s headlines this year, the story looked upbeat, with a bigger project backlog, new contracts across solar and metering, and even a joint venture aimed at advanced biofuels. For Ameresco shareholders, the loss from the start of the year was 36.4%, including dividends. If you were weighing a fresh position back on 1 January 2026, what clues were already on the table that this business strength might not translate into portfolio gains?

On Simply Wall St, a Narrative is an investor's thesis written down: the reasoning, plus the numbers it rests on. Run those numbers and you get an estimated Fair Value.

Ameresco is not the only name tied to this theme. Zero in on 42 power grid technology and infrastructure stocks and compare how each one is priced.

The Two Ameresco Stories Investors Had To Weigh

The shares cost US$29.29 at the start of the period, and Ameresco sat between two very different but reasonable stories about where the business might head next.

On the optimistic side, the bullish narrative put fair value at US$34.22, or 17% above the start price, assuming revenue growth of 9.1% and profit margins reaching 3.6% within three years as large energy infrastructure projects converted.

The bearish view argued for fair value of US$11, or 62% below the start price, focusing on supply chain strain and higher financing costs as key risks that could compress margins and weaken long term earnings stability.

What The Evidence Around Ameresco Actually Tested

The biggest development for Ameresco was the Neogenyx Fuels joint venture with HASI, which brought a US$100 million upfront payment and moved biofuels assets into a separate vehicle. That supported the optimistic case on liquidity and project pipeline. Q2 2026 results told a cooler story as revenue rose yet net income and net margin both slipped. The evidence cut both ways.

The key assumption here was margin expansion, not just contract wins. When you look at another energy contractor, check whether net margin is moving in the same direction as backlog and headline revenue.

Ameresco: What The Fall Left In Today’s Price

Ameresco shares now trade at US$19.5 from the start of the year, with the year to date return showing a loss of 36.4%. The selected Narrative’s Fair Value sits above the current price, based on its own assumptions about awards converting into higher quality earnings.

That view leans on backlog depth and recurring O&M and energy asset revenue rather than quick wins. A buyer at today’s level would need to judge that record data center and infrastructure awards convert to durable, higher margin cash flows quickly enough to outweigh balance sheet strain and execution risk.

"The main factor that needs to work in Ameresco’s favor is the conversion of its record Q2 2026 awards and growing long-term O&M and energy asset base into durable, higher-margin recurring revenue that more than offsets near-term losses, operational disruptions, and leadership turnover."

The price and this Narrative do not agree. → Uncover what this Narrative says Ameresco is actually worth

Find Your Own Contrarian Opportunity

Passing on this one could have spared you a loss. Where might you find the opposite surprise? Start looking for companies whose prices leave room for a better outcome than investors expect. These three trade below our estimated value.

• Company 1 - 37% below our estimate - supplies lidar sensors for large-volume vehicle programs as unit shipments grow.
• Company 2 - 46% below our estimate - expands a Pacific-focused banking platform after integrating a deposit-rich acquisition.
• Company 3 - 20% below our estimate - shifts its loan book toward higher yielding commercial credit and digital treasury tools.

Those are three of them. See every one of the 33 undervalued companies on it →

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com